PAM
GILD icon

PT Asset Management’s Gilead Sciences GILD Stock Holding History

PT Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-29,000
Closed -$1.97M – 107
2017
Q1 		$1.97M Sell
29,000
-16,500
-36% -$1.16M 0.52% 59
2016
Q4 		$3.26M Buy
45,500
+14,000
+44% +$1.04M 0.79% 41
2016
Q3 		$2.49M Buy
31,500
+15,000
+91% +$1.22M 0.58% 55
2016
Q2 		$1.38M Hold
16,500
– – 0.22% 95
2016
Q1 		$1.52M Buy
16,500
+13,300
+416% +$1.2M 0.39% 85
2015
Q4 		$324K Buy
+3,200
New +$333K 0.06% 221

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PT Asset Management's GILD Position: Q1 2017 in Review

PT Asset Management sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 26,400 shares — an estimated $1.86M sold.

PT Asset Management first reported a position in GILD in Q2 2016 and held it in 3 quarters. The position peaked at $1.89M in Q4 2016. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • PT Asset Management reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • PT Asset Management sold 26,400 Gilead Sciences shares in Q1 2017, an estimated $1.86M.
  • PT Asset Management first reported a position in Gilead Sciences in Q2 2016 and held it in 3 quarters.
  • PT Asset Management's Gilead Sciences position peaked at $1.89M in Q4 2016.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on PT Asset Management's 13F filing for Q1 2017, filed 15 May 2017.